Ryan's District Boards

By Kathryn Doyle NEW YORK (Reuters Health) - Colon and lung cancer patients who regularly took low-dose aspirin before their diagnosis tended to have less advanced tumors, in a new study. Scientists already knew that aspirin was tied to a decreased risk of death for people with colon cancer, said senior author Yudi Pawitan. "We showed evidence that it is also beneficial for lung cancer, and has both early and late protective effects," Pawitan, of the department of medical epidemiology and biostatistics at the Karolinska Institutet in Stockholm, Sweden, told Reuters Health. ...